Ovarian tumors form the second most common group of tumors in the female genital tract. However, they have a mortality higher than that of any otherfemale genital tract tumor. More women die of ovarian cancer than of all other female genital tract tumors combined, as shown inTable 17-1. 57...
Ovarian cancer, often referred to as the “silent killer,” is notoriously difficult to detect in its early stages, leading to a poor prognosis for many patients. Diagnosis is often delayed until the cancer has advanced, primarily due to its ambiguous an
He is also the president of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) His research focuses on advanced radiotherapy techniques for cancer treatment. With a career spanning several decades, Professor Pergolizzi has published numerous papers and has been instrumental in developing...
significantly decreased, suggesting a correlation between ovarian aging in these rats and a decrease in autophagic function [139,140]. And the treatment of rapamycin,
Are you afraid of developing cancer or from not being able to have children? If you answered yes, then let me tell you that I knowexactlyhow you feel, because I personally had gone through the same experience years ago. I have battled with chronic ovarian cysts for more than a decade un...
Ovarian cancer, often referred to as the “silent killer,” is notoriously difficult to detect in its early stages, leading to a poor prognosis for many patients. Diagnosis is often delayed until the cancer has advanced, primarily due to its ambiguous an
MPT0G066 inhibits cell viability in multi-drug resistant ovarian cancer cells. Drug resist- ance is an intractable problem in cancer treatment10. We used a multi-drug resistant ovarian cancer cell line, NCI/ADR-RES, to investigate whether MPT0G066 could overcome the drug resistance. As ...
It is notable that among them, DHA was the most effective and potent in inhibiting cell growth of ovarian cancer cells following 24 or 48 h exposure with a single dose of 20 µmol/L. For example, 24 h treatment with 20 µmol/L DHA reduced cell viability to approximately 50%, while...
of the very first things he said to me in 2012 was, “You are not a statistic.” The cancer statistics are actually at least 5 years old and the treatments have improved markedly since those statistics were published. I recently asked him a few questions regarding Ovarian Cancer treatment. ...
The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget. As of January 1, 2022, Oncotarget ...